B

PriceBarinthus Biotherapeutics

BRNS

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.

Historical stock price chart and annual return over the past years

-95%

4 years

% Total

BRNS
-52%

4 years

Annual Return

BRNS